Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell

Toxicology and Applied Pharmacology

Volumn 191, Issue 2, 2003, Pages 107-117

  Ramanathan, Lakshmi ^a   Gray, Wesley G ^a  

^a SOUTHERN UNIVERSITY   (United States)

Author keywords

Biomarkers; Gene expression; Genistein; Phytoestrogen

Indexed keywords

ANTIESTROGEN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; ESTRADIOL; FULVESTRANT; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN; ZEARALENONE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GENETICS; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; DIET; DNA DETERMINATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CODE; HORMONE ACTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PE 13 1 GENE; PRDA D GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; UPREGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0041733610     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00221-7     Document Type: Article

References (52)

1. Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-estrogens in Japanese men. Lancet. 342:1993;1209-1210.
2. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Arai Y., Uehara M., Sato Y., Kimira M., Eboshida A., Adlercreutz H., Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 10:2000;127-135.
4. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:2001;1269-1304.
5. Balk J.L., Whiteside D.A., Naus G., DeFerrari E., Roberts J.M. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J. Soc. Gynecol. Investig. 9:2002;238-242.
6. Barnes S., Peterson G.T., Coward L. Rational for the use of genistein-containing soy matrices in the chemoprevention trails for breast and prostate cancer. J. Cell. Biochem. 22:1995;181-187.
7. Barnes S., Peterson T.G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med. 208:1995;103-108.
8. Beekman J.M., Allan G.F., Tsai S.Y., Tsai M.-J., O'Malley B.W. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7:1993;1266-1274.
9. Boettger-Tong H., Murthy L., Chiappetta C., Kirkland J.L., Goodwin B., Adlercreutz H., Stancel G.M., Makela S. A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ. Health Perspect. 106:1998;369-373.
10. Brawley O.W., Barnes S.T. Potential agents for prostate cancer chemoprevention. Epidemiol. Rev. 23:2001;168-172.
11. Casanova M., You L., Gaido K.W., Archibeque-Engle S., Janszen D.B., Heck H.A. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol. Sci. 51:1999;236-244.
12. Cassidy A., Milligan S. How significant are environmental estrogens to women? Climacteric. 1:1998;229-242.
13. Cavailles V., Dauvois S., Danielian P.S., Parker M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA. 91:1994;10009-10013.
14. Cavarretta I.T., Mukopadhyay R., Lonard D.M., Cowsert L.M., Bennett C.F., O'Malley B.W., Smith C.L. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation. Mol. Endocrinol. 16:2002;253-270.
15. Chomczynski P., Sacchi N. Single step method of RNA isolationby acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
16. Clarkson T.B. Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 132:2002;566S-569S.
17. Colgan J., Wampler S., Manlet J.L. Interaction between a transcriptional activator and transcription factor IIB in vivo. Nature. 362:1993;549-552.
18. Cooper C.S. Applications of microarray technology in breast cancer research. Breast Cancer Res. 3:2001;158-175.
19. Czerwenka K.F., Manavi M., Hosmann J., Jelincic D., Pischinger K.I., Battistutti W.B., Behnam M., Kubista E. Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue. Cancer Detect. Prev. 25:2001;268-279.
20. Gorski J., Furlow J.D., Murdoch F.E., Fritsch M., Kaneko K., Ying C., Malayer J.R. Perturbations in the model of estrogen receptor regulation of gene expression. Biol. Reprod. 48:1993;8-14.
21. Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A., Ferno M., Peterson C., Meltzer P.S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61:2001;5979-5984.
22. Hedenfalk I., Duggan D., Chen Y., Radmacher M., Bittner M., Simon R., Meltzer P., Gusterson B., Esteller M., Kallioniemi O.P., Wilfond B., Borg A., Trent J. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344:2001;539-548.
23. Hoffman R. Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone comparison with genistein. Biochem. Biophys. Res. Commun. 211:1995;600-606.
24. Horowitz M.C. Cytokines and estrogen in bone anti-osteoporotic effects. Science. 260:1993;626-627.
25. Hubank M., Schatz D. Identifying differences in mRNA expression by representational difference anausis of cDNA. Nucleic Acid Res. 22:1994;5640-5648.
26. Humfrey C.D. Phytoestrogens and human health effects weighing up the current evidence. Nat. Toxins. 6:1998;51-59.
27. Jakowlew S.B., Breathnach R., Jeltsch J.M., Masiakowski P., Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res. 12:1984;2861-2878.
28. Jorgensen M., Vendelbo B., Skakkebaek N.E., Leffers H. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ. Health Perspect. 108:2000;403-412.
29. Kim M.K., Chung B.C., Yu V.Y., Nam J.H., Lee H.C., Huh K.B., Lim S.K. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women. Clin. Endocrinol. (Oxf.). 56:2002;321-328.
30. Knight D.C., Eden J.A. A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87:1996;897-904.
31. Komori A., Yatsunami J., Okabe S., Abe S., Hara K., Suganuma M., Kim S.J., Fujiki H. Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 23:1993;186-190.
32. Kuang W.W., Thompson D.A., Hoch R.V., Weigel R.J. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res. 26:1998;1116-1123.
33. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparision of the ligand binding specificity and trascript tissue distribution of the estrogen receptor α and β Endocrinology. 138:1997;863-870.
34. Liang P., Averboukh L., Keyomarsi K., Sager R., Pardee A.B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52:1992;6966-6968.
35. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
36. Makela S.I., Pylkkanen L.H., Santti R.S., Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J. Nutr. 125:1995;437-445.
37. Medlock K.L., Branham W.S., Sheehan D.M. The effects of phytoestrogens on neonatal rat uterine growth and development. Proc. Soc. Exp. Biol. Med. 208:1995;307-312.
38. Mei J., Yeung S.S., Kung A.W. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J. Clin. Endocrinol. Metab. 86:2001;5217-5221.
39. Mentor-Marcel R., Lamartiniere C.A., Eltoum I.E., Greenberg N.M., Elgavish A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res. 61:2001;6777-6782.
40. Messina M.J., Persky V., Setchell K.D., Barnes S. Soy intake and cancer risk a review of the in vitro and in vivo data. Nutr. Cancer. 21:1994;113-131.
41. Miksicek R.J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49:1994;153-160.
42. Musey P.L., Adlercreutz H., Gould K.G., Collins D.C., Fotsis T., Bannwart C., Makela T., Wahala K., Brunow G., Hase T. Effect of diet on lignans and isoflavonoid phytoestrogens in chimpanzees. Life Sci. 57:1995;655-664.
43. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer. 30a:1994;1675-1682.
44. Park O.K., Mayo K.E. Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge. Mol. Endocrinol. 5:1991;967-978.
45. Robyr D., Wolffe A.P., Wahli W. Nuclear hormone receptor coregulators in action diversity for shared tasks. Mol. Endocrinol. 14:2000;329-347.
46. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science. 289:2000;1508-1514.
47. Roy D., Angelini N.L., Belsham D.D. Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons. Endocrinology. 140:1999;5045-5053.
48. Santell R.C., Chang Y.C., Nair M.G., Helferich W.G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J. Nutr. 127:1997;263-269.
49. Stahl S., Chun T.Y., Gray W.G. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol. Appl. Pharmacol. 152:1998;41-48.
50. Uehar M., Arai Y., Watanabe S., Adlercreutz H. Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Biofactors. 12:2000;217-225.
51. Vercoutter-Edouart A.S., Czeszak X., Crepin M., Lemoine J., Boilly B., Le Bourhis X., Peyrat J.P., Hondermarck H. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp. Cell Res. 262:2001;59-68.
52. Xu X., Wang H.-J., Murphy P., Cook L., Hendrich S. Daidzein is more bioacailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124:1994;825-832.